Upgrade to SI Premium - Free Trial

Biogen (BIIB) PT Raised to $280 at Stifel

April 25, 2017 11:18 AM
Stifel analyst Thomas Shrader raised his price target on Biogen (NASDAQ: BIIB) to $280.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles